Abstract:The role of insulin resistance and triglyceride‐glucose index (TyG) has been investigated in cognitive decline and dementia. Based on 17 included studies, patients with cognitive decline had significantly higher levels of TyG index compared to controls. TyG, as a surrogate marker of insulin resistance, could be a potentially useful biomarker in dementia and cognitive decline. Background Cognitive decline and dementia are debilitating conditions that compromise the quality of life and charge the healthcare system with a substantial socioeconomic burden. In this context, emerging evidence supports an association between the triglyceride‐glucose index (TyG), a surrogate insulin resistance marker, and cognitive decline and dementia. Hence, we systematically reviewed the studies assessing the TyG index in patients with cognitive decline and their controls. Methods Online international databases (PubMed, Scopus, Embase, and the Web of Science) were searched comprehensively for studies showing the TyG index in patients with cognitive decline/impairment. Random‐effect meta‐analyses were conducted to calculate the standardized mean difference (SMD), pooled odds ratio (OR), and pooled area under the curve (AUC), in addition to 95% confidence intervals (CIs) for the comparisons of groups. Results Seventeen studies were included in our analysis. Then, we conducted a meta‐analysis, demonstrating that patients with cognitive decline had significantly higher levels of TyG index than those without (SMD 0.83, 95% CI 0.16 to 1.50, p = 0.015). Moreover, our data showed that a 1‐unit increase in the TyG index was associated with higher odds of cognitive decline (adjusted OR [aOR] 2.86, 95% CI 1.49 to 5.50, p = 0.002). Further, we observed that patients in the fourth TyG quartile with higher values of the TyG index than the first quartile presented with more increased cognitive decline (aOR 1.62, 95%CI 1.11 to 2.38, p = 0.013). Finally, pooled AUC data for the diagnostic performance of the TyG index resulted in an overall AUC value of 0.73 (95% CI 0.66 to 0.79). Sensitivity and specificity were also calculated as 0.695 and 0.687, respectively. Conclusion This study supports the clinical utility of the TyG index in patients with cognitive decline and solicits more focused studies to consolidate its usage in clinical settings and real‐world practice.

Assessing the association between triglyceride-glucose index and atrial fibrillation: a systematic review and meta-analysis

U-shaped association between the triglyceride–glucose index and atrial fibrillation incidence in a general population without known cardiovascular disease

Association between the Triglyceride–Glucose Index and Non-Alcoholic Fatty Liver Disease in patients with Atrial Fibrillation

Triglyceride-glucose index and heart failure: a systematic review and meta-analysis

Correlation between the triglyceride-glucose index and the onset of atrial fibrillation in patients with non-alcoholic fatty liver disease

The triglyceride-glucose index as a clinical useful marker for metabolic associated fatty liver disease (MAFLD): a population-based study among Iranian adults

Usefulness of Triglyceride-glucose index for detecting prevalent atrial fibrillation in a type 2 diabetic population.

Investigating the association between the triglyceride-glucose index and peripheral artery disease: a systematic review and meta-analysis

Association of the triglyceride glucose index with all-cause and cardiovascular mortality in a general population of Iranian adults

Triglyceride-Glucose Index Predicts Major Adverse Cardiovascular and Cerebrovascular Events in Patients with Atrial Fibrillation

Non-insulin-based insulin resistance indexes in predicting atrial fibrillation recurrence following ablation: a retrospective study

Association between triglyceride glucose index and risk of cerebrovascular disease: systematic review and meta-analysis

Association of triglyceride glucose index with cardiovascular events: insights from the Isfahan Cohort Study (ICS)

The association between triglyceride glucose-body mass index and all-cause mortality in critically ill patients with atrial fibrillation: a retrospective study from MIMIC-IV database

Triglyceride-glucose index and obstructive sleep apnea: a systematic review and meta-analysis

Exploring the Association Between Cognitive Decline and Triglyceride‐Glucose Index: A Systematic Review and Meta‐Analysis

Association Between the Cumulative Triglyceride-Glucose Index and the Recurrence of Atrial Fibrillation after Radiofrequency Catheter Ablation.

The importance of assessing the triglyceride-glucose index (TyG) in patients with depression: A systematic review

Triglyceride-glucose index as a predictor of cardiac adverse events in acute coronary syndrome patients undergoing percutaneous coronary intervention: role of diabetes

Fasting plasma glucose is a stronger predictor of diabetes than triglyceride–glucose index, triglycerides/high-density lipoprotein cholesterol, and homeostasis model assessment of insulin resistance: Tehran Lipid and Glucose Study